Stocks
Shuttle Pharmaceuticals Holdings, Inc.SHPH
NASDAQHealthcareBiotechnology$4.61
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for cancer and radiation-induced side effects. Its lead candidate, SHP2, is in early-stage trials for solid tumors, and investors track the stock for its speculative upside in oncology. The company has no approved products and relies on equity raises to fund operations.
52W Range: $2.58-$44.40
Congressional Interest in Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
No congressional trades have been disclosed for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SHPH?
No congressional trades found for this stock.